Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 107075310
Gene Symbol: MTCO2P12
MTCO2P12
0.010 Biomarker disease BEFREE Inhibition of COX-2 Pathway as a Potential Prophylaxis Against Arthrofibrogenesis in a Rabbit Model of Joint Contracture. 31410880 2019
Entrez Id: 5290
Gene Symbol: PIK3CA
PIK3CA
0.010 Biomarker disease BEFREE Curcumin Inhibits Joint Contracture through PTEN Demethylation and Targeting PI3K/Akt/mTOR Pathway in Myofibroblasts from Human Joint Capsule. 31511778 2019
Entrez Id: 5291
Gene Symbol: PIK3CB
PIK3CB
0.010 Biomarker disease BEFREE Curcumin Inhibits Joint Contracture through PTEN Demethylation and Targeting PI3K/Akt/mTOR Pathway in Myofibroblasts from Human Joint Capsule. 31511778 2019
Entrez Id: 5293
Gene Symbol: PIK3CD
PIK3CD
0.010 Biomarker disease BEFREE Curcumin Inhibits Joint Contracture through PTEN Demethylation and Targeting PI3K/Akt/mTOR Pathway in Myofibroblasts from Human Joint Capsule. 31511778 2019
Entrez Id: 5294
Gene Symbol: PIK3CG
PIK3CG
0.010 Biomarker disease BEFREE Curcumin Inhibits Joint Contracture through PTEN Demethylation and Targeting PI3K/Akt/mTOR Pathway in Myofibroblasts from Human Joint Capsule. 31511778 2019
Entrez Id: 5696
Gene Symbol: PSMB8
PSMB8
0.010 GeneticVariation disease BEFREE CANDLE syndrome is caused by mutations in PSMB8, a gene recently reported to cause "JMP" syndrome (joint contractures, muscle atrophy, microcytic anemia, and panniculitis-induced childhood-onset lipodystrophy) in adults. 21953331 2012
Entrez Id: 5743
Gene Symbol: PTGS2
PTGS2
0.010 Biomarker disease BEFREE Inhibition of COX-2 Pathway as a Potential Prophylaxis Against Arthrofibrogenesis in a Rabbit Model of Joint Contracture. 31410880 2019
Entrez Id: 6232
Gene Symbol: RPS27
RPS27
0.010 Biomarker disease BEFREE Skeletal abnormalities (for MPS IVA and MPS VI), joint contractures (for MPS II), and typical facial features (for MPS I) were the most frequently reported first signs/symptoms. 18546277 2008
Entrez Id: 29072
Gene Symbol: SETD2
SETD2
0.010 Biomarker disease BEFREE The present study demonstrates the important role of HIF-1 in the initial progression of immobilization-induced joint contracture, and indicates the possibility of molecular treatment to prevent the progression of joint contracture prior to intervention with physical therapy. 27352194 2016
Entrez Id: 6863
Gene Symbol: TAC1
TAC1
0.010 Biomarker disease BEFREE This finding will motivate future studies to optimize interventions that target SP to reduce the formation of post-traumatic joint contractures. 28671282 2018
Entrez Id: 7042
Gene Symbol: TGFB2
TGFB2
0.010 Biomarker disease BEFREE Further, the evidence of TGF β2 pathogenetic effects in tenocytes provides the first mechanistic insight into occurrence of joint contractures in muscular laminopathies. 29693488 2018
Entrez Id: 26092
Gene Symbol: TOR1AIP1
TOR1AIP1
0.300 Biomarker disease GENOMICS_ENGLAND Mutation in TOR1AIP1 encoding LAP1B in a form of muscular dystrophy: a novel gene related to nuclear envelopathies. 24856141 2014
Entrez Id: 23430
Gene Symbol: TPSD1
TPSD1
0.010 Biomarker disease BEFREE Serum Mast Cell Tryptase as a Marker of Posttraumatic Joint Contracture in a Rabbit Model. 28212251 2017
Entrez Id: 7272
Gene Symbol: TTK
TTK
0.010 Biomarker disease BEFREE Skeletal abnormalities (for MPS IVA and MPS VI), joint contractures (for MPS II), and typical facial features (for MPS I) were the most frequently reported first signs/symptoms. 18546277 2008